BD 231705 - Disk Susceptibility Sensi-Disc Levofloxacin 5mcg Accurate Antimicrobial Sensitivity Testing for Broad-Spectrum Bacteria, EA
The BD 231705 Disk Susceptibility Sensi-Disc Levofloxacin 5mcg is a high-quality antimicrobial susceptibility testing (AST) reagent used to determine bacterial sensitivity to levofloxacin, a broad-spectrum fluoroquinolone antibiotic. Each sterile paper disk contains 5 micrograms of levofloxacin and is designed for use in standardized disk diffusion methods such as the Kirby-Bauer test. Manufactured under BDs rigorous quality control standards, these disks ensure consistent diffusion and accurate inhibition zone measurements, enabling laboratories to generate reliable, reproducible results that guide appropriate antibiotic therapy.
| Manufacturer | Application | Storage Requirements |
| 231705 | Antimicrobial Susceptibility Testing Disc | Requires Refrigeration |
Key Benefits
The BD 231705 Levofloxacin 5mcg Sensi-Disc provides exceptional accuracy, consistency, and performance in antimicrobial testing. Each disk delivers a precise concentration of levofloxacin to ensure standardized diffusion and consistent susceptibility results across laboratories. The sterile, single-use format minimizes contamination risks and enhances workflow efficiency. With proven batch-to-batch consistency, these Sensi-Discs improve diagnostic reliability, support antibiotic stewardship efforts, and help clinicians optimize treatment decisions for bacterial infections.
Compatibility and Applications
The BD 231705 Sensi-Disc is compatible with standard Mueller-Hinton agar and aligns with CLSI (Clinical and Laboratory Standards Institute) and EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines. It is used to test a wide range of Gram-positive and Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus pneumoniae. Levofloxacins broad antimicrobial spectrum makes this Sensi-Disc suitable for clinical diagnostic laboratories, research facilities, and hospital microbiology units monitoring antibiotic resistance patterns.
Usage Guidelines
For best results, perform susceptibility testing using CLSI-approved protocols. Inoculate a Mueller-Hinton agar plate uniformly with a standardized bacterial suspension equivalent to a 0.5 McFarland standard. Apply the BD 231705 Levofloxacin 5mcg disk aseptically using sterile forceps or a disk dispenser. Incubate the plate at 3537C for 1618 hours under aerobic conditions. After incubation, measure the diameter of the inhibition zone in millimeters and interpret results based on CLSI or EUCAST standards. Store disks at 28C in a dry, dark location and allow to equilibrate to room temperature before opening to prevent condensation.
Certifications, Safety Standards, and Regulatory Approvals
The BD 231705 Levofloxacin Sensi-Disc is manufactured under ISO 9001 and ISO 13485 certified quality systems, ensuring compliance with FDA and CE regulatory requirements for in vitro diagnostic use. Each batch undergoes rigorous testing for antibiotic potency, diffusion uniformity, and sterility. BDs quality assurance process guarantees performance in alignment with international standards, providing laboratories with accurate, validated antimicrobial test materials.
Comparison with Competitor Products
Compared to generic antibiotic testing disks, BDs Sensi-Discs offer unmatched precision, stability, and reproducibility. Competitor disks may show variability in antibiotic concentration or diffusion rates, leading to inconsistent inhibition zones. BDs advanced manufacturing ensures uniform impregnation and consistent drug distribution across all disks. The superior packaging preserves disk potency and prevents moisture degradation, ensuring accurate results even with long-term storage.
Typical User Profile and Application Scenarios
The BD 231705 Levofloxacin 5mcg Sensi-Disc is primarily used by microbiologists, laboratory technologists, and infection control specialists. It is widely used in hospital diagnostic laboratories, clinical research facilities, pharmaceutical quality control, and public health laboratories conducting antibiotic resistance surveillance. The product is essential for monitoring fluoroquinolone resistance trends and guiding effective treatment strategies for bacterial infections in healthcare settings.
Best Practices for Use and Maintenance
Use aseptic technique when handling Sensi-Discs and always store them in their original, tightly sealed container to prevent moisture exposure. Allow refrigerated disks to reach room temperature before use to maintain potency. Use appropriate control strains such as E. coli ATCC 25922 or Pseudomonas aeruginosa ATCC 27853 to verify test validity. Do not reuse or re-sterilize disks. Dispose of all used plates and materials as biohazard waste according to institutional and regulatory safety protocols.
Regulatory and Safety Information
The BD 231705 Levofloxacin 5mcg Sensi-Disc is intended for professional in vitro diagnostic use only. It meets international safety and regulatory standards under FDA, CE, and ISO certifications. While non-toxic under normal laboratory use, all biological testing materials should be handled following biosafety level 2 (BSL-2) guidelines. Always use personal protective equipment (PPE) such as gloves, lab coats, and eye protection during testing and disposal.
How to Order
To purchase the BD 231705 Disk Susceptibility Sensi-Disc Levofloxacin 5mcg, add the product to your cart and complete your transaction via CIA Medicals secure online checkout. For bulk or institutional orders, contact CIA Medical customer service at (312) 275-5850 or submit your request through the contact form on this page. Our support team can assist with pricing, availability, and technical information to help integrate this product into your laboratorys antimicrobial testing workflow.
